Kimitoshi Kimura

Kimitoshi Kimura

Auto-generated profile, based on publicly available information

Kimitoshi Kimura

Department of Neurology, Graduate School of Medicine Kyoto University Kyoto Japan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
KKKimitoshi Kimura
Kimitoshi Kimura
HHHirohiko Hohjoh
Hirohiko Hohjoh
MFMasashi Fukuoka
Masashi Fukuoka
WSWakiro Sato
Wakiro Sato
SOShinji Oki
Shinji Oki
TYTakashi Yamamura
Takashi Yamamura
Multiple sclerosis (MS) is a T cell-mediated autoimmune disease of the central nervous system. Foxp3+ regulatory T (Treg) cells are reduced in frequency and dysfunctional in patients with MS, but the underlying mechanisms of this deficiency are unclear. Here, we show that induction of human IFN-γ−IL-17A−Foxp3+CD4+ T cells is inhibited in the presence of circulating exosomes from patients with MS. The exosomal miRNA profile of patients with MS differs from that of healthy controls, and let-7i, which is markedly increased in patients with MS, suppresses induction of Treg cells by targeting insulin like growth factor 1 receptor (IGF1R) and transforming growth factor beta receptor 1 (TGFBR1). Consistently, the expression of IGF1R and TGFBR1 on circulating naive CD4+ T cells is reduced in patients with MS. Thus, our study shows that exosomal let-7i regulates MS pathogenesis by blocking the IGF1R/TGFBR1 pathway.

24 August 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
DTDaiki Takewaki
Daiki Takewaki
WSWataru Suda
Wataru Suda
WSWakiro Sato
Wakiro Sato
LTLena Takayasu
Lena Takayasu
NKNaveen Kumar
Naveen Kumar
TYTakashi Yamamura
Takashi Yamamura
Significance: We have compared gut microbiomes in the different stages of multiple sclerosis (MS) based on both microbial and functional analyses using fecal samples. Together with microbial composition data, metagenomic functional and metabolite data revealed a reduced level of microbial butyrate and propionate biosynthesis in the gut of relapsing remitting MS (RRMS). On the other hand, in the gut of secondary progressive MS (SPMS), we revealed an enhancement in microbial DNA mismatch repair, which was consistent with excessive fecal oxidation shown in sulfur metabolomic analysis. As elevated oxidative stress is closely associated with chronic neuroinflammation and neurodegeneration, the present result opens a way to microbiome data-assisted management of MS, useful for prevention of disease progression.

9 April 2025 in Nature
Verified
Journal Article
Closed access
PDF file
KKKimitoshi Kimura
Kimitoshi Kimura
ASAyshwarya Subramanian
Ayshwarya Subramanian
ZYZhuoran Yin
Zhuoran Yin
AKAhad Khalilnezhad
Ahad Khalilnezhad
YWYufan Wu
Yufan Wu
VKVijay K. Kuchroo
Vijay K. Kuchroo

4 March 2021 in Neurology Neuroimmunology & Neuroinflammation
Verified
Journal Article
Open access
PDF file
SAShinji Ashida
Shinji Ashida
HOHirofumi Ochi
Hirofumi Ochi
MHMio Hamatani
Mio Hamatani
CFChihiro Fujii
Chihiro Fujii
KKKimitoshi Kimura
Kimitoshi Kimura
TKTakayuki Kondo
Takayuki Kondo
Objective To clarify functional alterations of follicular helper T cells (Tfh) in myasthenia gravis (MG) because Tfh play important roles in helping B cells generate antibody-producing cells. Methods A total of 24 immunotherapy-naive patients with anti–acetylcholine receptor (AchR) antibody–positive MG and 18 age-matched healthy subjects (HS) were enrolled. Samples from 6 patients were available for posttreatment analysis. Subsets of circulating Tfh (cTfh) and B cells were identified by flow cytometry analysis of surface molecules. Cytokine production by isolated cTfh subsets from 5 patients with MG and 5 HS was measured in vitro. Analysis was performed to examine the correlation between the frequency of cTfh subsets and that of plasmablasts and between cTfh subsets and the quantitative MG score. Results cTfh increased with elevated expression of inducible T-cell costimulator (ICOS) in patients with MG. cTfh shifted to Th2 and Th17 over Th1 in MG. ICOShighcTfh produced significantly higher levels of interleukin (IL)-21, IL-4, and IL-17A than ICOSlow cTfh only in patients with MG. The frequency of cTfh within CD4 T cells was more closely associated with disease severity than the serum anti-AchR antibody titer and frequency of plasmablasts within B cells. Abnormalities of cTfh were improved after immunotherapy in parallel with clinical improvement. Conclusions Alternation of cTfh is a key feature in the development of MG and may become a biomarker for disease severity and therapeutic efficacy. Classification of Evidence This study provides Class II evidence that the level of cTfh is associated with disease severity in patients with MG.

1 January 2024 in Neurology Neuroimmunology & Neuroinflammation
Verified
Journal Article
Open access
PDF file
KKKimitoshi Kimura
Kimitoshi Kimura
RNRyusei Nishigori
Ryusei Nishigori
MHMio Hamatani
Mio Hamatani
MSMasanori Sawamura
Masanori Sawamura
SAShinji Ashida
Shinji Ashida
TKTakayuki Kondo
Takayuki Kondo
Background and Objectives Resident memory T (Trm) cells are a unique population that can survive and function in a compartmentalized tissue with inflammatory potential. We aim to investigate the alteration of Trm population in acute/chronic inflammatory and neurodegenerative diseases in the CNS. Methods The frequencies of CD4+ and CD8+ T cells expressing both CD69 and CD103, the markers for Trm cells, were quantified in the peripheral blood and CSF (n = 80 and 44, respectively) in a cross-sectional manner. The transcriptional profile of Trm-like population in the CSF was further analyzed using a public single-cell dataset. Results The frequency of CD69+CD103+CD8+ T cells was strikingly higher in the CSF than in the peripheral blood (among memory fraction, 13.5% vs 0.11%, difference (mean [SE]): 13.4% [2.9]). This CD69+CD103+CD8+ T-cell population was increased in the CSF from patients with chronic inflammatory diseases including multiple sclerosis and with neurodegenerative diseases such as Parkinson disease and Alzheimer disease compared with controls (11.5%, 13.0%, 8.1% vs 2.9%, respectively). By contrast, the frequency was not altered in acute inflammatory conditions in the CNS (4.0%). Single-cell RNAseq analysis confirmed Trm signature in CD69+CD103+CD8+ T cells in the CSF, supporting their Trm-like phenotype, which was not clear in controls. Discussion Collectively, an increase in CD69+CD103+CD8+ Trm-like population in the CSF is related with both chronic neuroinflammatory and some neurodegenerative diseases in the CNS, suggesting a partially shared pathology in these diseases.

24 April 2020 in Clinical and Experimental Neuroimmunology
Verified
Journal Article
Closed access
PDF file
KKKimitoshi Kimura
Kimitoshi Kimura